TownSquare Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,081
| Closed | -$7.28K | – | 1312 |
|
|
2023
Q4 | $7.28K | Hold |
1,081
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q3 | $9.89K | Hold |
1,081
| – | – | ﹤0.01% | 1097 |
|
|
2023
Q2 | $22.8K | Hold |
1,081
| – | – | ﹤0.01% | 1047 |
|
|
2023
Q1 | $29.1K | Hold |
1,081
| – | – | ﹤0.01% | 961 |
|
|
2022
Q4 | $38.3K | Hold |
1,081
| – | – | ﹤0.01% | 917 |
|
|
2022
Q3 | $244K | Hold |
1,081
| – | – | 0.01% | 645 |
|
|
2022
Q2 | $204K | Hold |
1,081
| – | – | 0.01% | 660 |
|
|
2022
Q1 | $269K | Hold |
1,081
| – | – | 0.01% | 613 |
|
|
2021
Q4 | $168K | Hold |
1,081
| – | – | ﹤0.01% | 689 |
|
|
2021
Q3 | $217K | Hold |
1,081
| – | – | 0.01% | 652 |
|
|
2021
Q2 | $285K | Hold |
1,081
| – | – | 0.01% | 507 |
|
|
2021
Q1 | $287K | Hold |
1,081
| – | – | 0.01% | 483 |
|
|
2020
Q4 | $399K | Buy |
+1,081
| New | +$399K | 0.02% | 402 |
|